Cinclus Pharma Holding Management
Management criteria checks 3/4
Cinclus Pharma Holding's CEO is Christer Ahlberg, appointed in Jan 2021, has a tenure of 3.5 years. total yearly compensation is SEK5.18M, comprised of 67.1% salary and 32.9% bonuses, including company stock and options. directly owns 0.17% of the company’s shares, worth SEK2.62M. The average tenure of the management team and the board of directors is 3.5 years and 8.5 years respectively.
Key information
Christer Ahlberg
Chief executive officer
SEK 5.2m
Total compensation
| CEO salary percentage | 67.1% |
| CEO tenure | 3.5yrs |
| CEO ownership | 0.2% |
| Management average tenure | 3.5yrs |
| Board average tenure | 8.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -SEK 203m |
| Dec 31 2023 | SEK 5m | SEK 3m | -SEK 215m |
| Dec 31 2022 | SEK 5m | SEK 4m | -SEK 249m |
| Dec 31 2021 | SEK 4m | SEK 2m | -SEK 76m |
Compensation vs Market: Christer's total compensation ($USD485.09K) is above average for companies of similar size in the Swedish market ($USD281.24K).
Compensation vs Earnings: Christer's compensation has been consistent with company performance over the past year.
CEO
Christer Ahlberg (53 yo)
3.5yrs
Tenure
SEK 5,182,000
Compensation
Mr. Christer Ahlberg serves as the Chief Executive Officer & President of Cinclus Pharma Holding AB Since 2021. He served as Director at Glycorex Transplantation AB (publ) since 2020. He serves as Director...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-founder & Chairman of the Board | 10.5yrs | SEK 494.00k | 2.23% SEK 34.0m | |
| CEO & President | 3.5yrs | SEK 5.18m | 0.17% SEK 2.6m | |
| Co-founder & Director | no data | SEK 2.28m | 4.35% SEK 66.3m | |
| Co-Founder & Chief Scientific Officer | 3.5yrs | no data | 4.1% SEK 62.6m | |
| Chief Financial Officer | 3.5yrs | no data | 0.017% SEK 262.4k | |
| Chief Operating Officer | 3.5yrs | no data | no data | |
| Head of CMC & IP | 1.5yrs | no data | no data | |
| Chief Medical Officer | 2.5yrs | no data | no data | |
| Head of Regulatory Affairs | 1.5yrs | no data | no data |
3.5yrs
Average Tenure
58yo
Average Age
Experienced Management: CINPHA's management team is considered experienced (3.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-founder & Chairman of the Board | 10.5yrs | SEK 494.00k | 2.23% SEK 34.0m | |
| Co-founder & Director | 10.5yrs | SEK 2.28m | 4.35% SEK 66.3m | |
| Independent Director | 3.5yrs | SEK 290.00k | 0.10% SEK 1.5m | |
| Independent Director | 7.5yrs | SEK 329.00k | 0.19% SEK 2.9m | |
| Independent Director | 2.5yrs | SEK 265.00k | no data | |
| Independent Director | 8.5yrs | SEK 265.00k | 0.045% SEK 682.2k | |
| Independent Director | 8.5yrs | SEK 240.00k | 0.020% SEK 312.0k |
8.5yrs
Average Tenure
67yo
Average Age
Experienced Board: CINPHA's board of directors are considered experienced (8.5 years average tenure).